CAMP4 Therapeutics prices 5M share offering at $6.00, expects $28M net proceeds

Camp4 Therapeutics Corp

CAMP4 Therapeutics priced public offering of 5,000,000 shares of common stock at $6.00 per share.
Net proceeds expected to be approximately $28.0 million after underwriting discounts and expenses.
Underwriting agreement with Leerink Partners LLC; closing expected on or about December 19, 2025.
Executive officers, directors, and certain stockholders agreed to a 60-day lock-up on share sales.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.99

Camp4 Therapeutics Corp entered into Underwriting Agreement with Leerink Partners LLC valued at Offering of 5,000,000 shares of common stock at $6.00 per share, net proceeds ~$28.0 million (effective 2025-12-18).

Action: entry
Agreement: underwriting
Counterparty: Leerink Partners LLC
Value: Offering of 5,000,000 shares of common stock at $6.00 per share, net proceeds ~$28.0 million
Effective: 2025-12-18

Exact text from the filing

On December 18, 2025, CAMP4 Therapeutics Corporation (the “Company”), entered into an underwriting agreement (the “ Underwriting Agreement ”) with Leerink Partners LLC (“ Leerink Partners ”), relating to an offering of 5,000,000 shares (the “ Shares ”), of its common stock, par value $0.0001 per share (the “ Common Stock ”), at an offering price of $6.00 per Share.

View on SEC.gov

801 material agreements filed in the last 30 days. Browse all material agreements →

Camp4 Therapeutics Corp filing history →

Source: SEC EDGAR

accession 0001628280-25-058009

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.